SARS-CoV-2 blocked by antiviral substances discovered in South Korean plants
South Korean researchers identified two saponins there were highly effective in blocking the ability of SARS-CoV-2 variants to enter cells.
List view / Grid view
South Korean researchers identified two saponins there were highly effective in blocking the ability of SARS-CoV-2 variants to enter cells.
US scientists, using CRISPR technology, removed specific genes in humans to allow the immune system to be more activated against cancer.
Australian researchers have tested a new nasal vaccine in mice, with the potential enhance protection against COVID-19.
In this article, Drug Target Review’s Ria Kakkad shares some of the most recent progress in discovering a drug for COPD, a disease that remains a major challenge in the medical industry.
A study has suggested that a new vaccine could prevent fentanyl from entering the brain, after showing success in rats.
US researchers, using a 3D neural tissue model, found that compounds from green tea and resveratrol could diminish Alzheimer’s amyloid plaques in lab tests, with no side effects.
This Malvern Panalytical guide explores the use of Xray powder diffraction (XRPD) as a powerful tool to develop and improve pharmaceutical formulation.
A new pre-clinical study has utilised nanoparticles to attach immune-activating molecules to cancer cells.
NIH researchers who intravenously delivered a cancer vaccine to mice report that it increased the number of T cells able to combat tumours.
The research has shown in high-resolution detail how certain lipids interact with pacemaker ion channels to enhance their activity.
In this exclusive Q&A, Dr Robert Baldock, Research Scientist at the University of Portsmouth, discusses the compound hydroquinine and how it could be used as an effective weapon against a pathogen that causes serious infections in humans, mostly hospital patients.
The study, involving mice, found that the neurotransmitter can act as a break to dopamine.
Looking for solutions to resolve your unique challenges? We offer several customized products and services to move your discovery forward.
German researchers have designed peptides that bind to amyloidogenic proteins linked to Alzheimer’s and type 2 diabetes, to effectively suppress both cytotoxic amyloid aggregation and amyloid cross-accelerating interactions.
US researchers have engineered bacteriophages to deliver CRISPR-Cas payloads for targeted editing of a bacterium.